The QualityStocks Daily Wednesday, May 1st, 2019

Today's Top 3 Investment Newsletters

MarketClub Analysis (ABIO) +98.64%

StockMarketWatch (ENPH) +29.28%

StreetInsider (NUS) +26.44%

The QualityStocks Daily Stock List

Vitalibis, Inc. (VCBD)

Simply Wall St, Wallet Investor, Trading View, Invest Tribune, Stockhouse, InvestorsHub, Stockwatch, Wallmine, Real Investment Advice, Investors Hangout, Investors News, Teletrader, Dividend Investor, 4-Traders, GlobeNewswire, and Market Screener reported previously on Vitalibis, Inc. (VCBD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vitalibis, Inc. is a technology based formulator of premium hemp-based cannabidiol (CBD) wellness products. The Company is also a formulator of safe personal care and nutritional products. Its sales model maximizes a one-brand, multi-channel framework. The Company was previously known as Sheng Ying Entertainment Corp. It changed its corporate name to Vitalibis, Inc. in February of 2018. OTCQB-listed, Vitalibis is headquartered in Las Vegas, Nevada.

All of the Company's products are validated by independent third-party testing labs. Vitalibis offers its full spectrum, phyto-cannabinoid rich hemp oil. Vitalibis sources premium, organically grown industrial hemp from Colorado. The Company employs a patent-pending extraction process that uses precise bursts of heat in comparison to harmful solvents or CO2.

Regarding Personal Care products, Vitalibis' screening process eliminates more than 1,400 ingredients before formulation starts. Furthermore, Vitalibis utilizes cold processing techniques to retain more of its ingredient benefits. Moreover, the Company's nutritional products are certified organic and formulated specifically for optimal results. Vitalibis has partnered with the best leaders in quantum neurology and holistic health to create these products.

Last month, Vitalibis announced that it appointed baseball legend Mr. Dusty Baker to its Advisory Board and as a Founding Ambassador working together within the sports world to educate and spread awareness of the benefits of the Company's full-spectrum phyto-cannabinoid rich hemp oil products. As an Advisor, Mr. Baker will work with the Vitalibis management team on different company strategies and priorities. As a Founding Ambassador, he will help educate and provide awareness of the Vitalibis products, social mission and technology. These efforts will center on boosting sales and more collaborations with other Ambassadors to assist in growing the Vitalibis brand.

Also in April, Vitalibis announced that it launched its new premium Vitalibis Signature 600 CBD hemp oil now available for purchase on its direct to consumer website. The Vitalibis Signature 600 is a premium full spectrum, phyto-cannabinoid rich hemp oil blended with organic Medium Chain Triglycerides from coconut oil. This product contains roughly 600 mg of naturally occurring cannabidiol (CBD) per bottle. It also contains other natural cannabinoids and terpenes, per bottle.

Vitalibis, Inc. (VCBD), closed Wednesday's trading session at $1.05, up 5.00%, on 7,777 volume with 14 trades. The average volume for the last 3 months is 8,459 and the stock's 52-week low/high is $0.55/$4.91.

chart

Comepay, Inc. (CMPY)

InvestorsHub, Business Insider, and Nasdaq reported on Comepay, Inc. (CMPY), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Comepay, Inc. provides Internet acquiring and support services. In addition, the Company engages in facilitating instant payments and internet based payment transactions via kiosks, mobile interfaces, and Web-based applications. The Comepay group of companies includes Comepay, RP Systems, M-NN LLC, and Chek-Online. Comepay has its corporate headquarters in Vaughan, Ontario.

The Company also leases and sells cash registers and point of sale (POS) systems. This includes its recently developed proprietary multifunctional smart POS fiscal cash register system. Comepay processes more than 4.7 million customer payments monthly. At present, the Company has greater than 12,700 kiosks throughout Russia.

The above-mentioned companies are now concentrating their planned business expansion on the smart POS fiscal cash register system "Cassatka". This is to help businesses comply with Russian taxation legislation, 54-FZ, that required 1.2 million businesses in fiscal 2018, and a further 1.4 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers.

The Cassatka is Comepay's multifunctional smart POS online fiscal cash register. Cassatka can process payments and meet fiscal data storage requirements for participating businesses. Cassatka is a convenient and cost competitive solution for businesses to meet the new federal taxation requirements in Russia.

As the companies expand their business model, Comepay expects to offer blockchain acquiring services and to accept payments in numerous crypto currencies on the Cassatka. The Comepay group of companies currently earn revenue from an array of channels. These include fee-based commissions on payment processing for cash and debit card payments, software licensing, kiosk placement fees and other rental fees for cash registers and associated equipment.

This past February, Comepay announced that its wholly-owned subsidiary, Chek-Online LLC, again added more functionality to its smart terminals through integrating merchant acquiring services from two large banks in Russia for its versatile handheld Cassatka-Mini terminal. Chek-Online is a foremost manufacturer of fiscal cash registers in Russia, and the developer of the family of Cassatka smart terminals.

Chek-Online plans to expand to several more partner banks for trade acquiring for its Cassatka-Mini Smart terminal. Nonetheless, the integration process has already been launched with two large banks based in Russia, VTB Bank and Otkritie FC Bank.

In April, Comepay announced that Chek-Online concluded an agreement with the National Payment Card System (NSPK) for the use of contactless payment system "Mir" for the Cassatka Mini series of smart terminals. NSPK is the operator of the Russian national contactless payment system "Mir". NSPK recently concluded an agreement with Chek-Online for the supply of materials required to develop customized solutions for the Cassatka Mini mobile smart terminal. This include contactless payments.

Comepay, Inc. (CMPY), closed Wednesday's trading session at $1.70, down 0.58%, on 5,535 volume with 26 trades. The average volume for the last 3 months is 16,157 and the stock's 52-week low/high is $0.75/$5.25.

chart

Simplicity Esports and Gaming Company (WINR)

Investor Ideas, Marketbeat, Teletrader, GlobeNewswire, and Ticker Report reported earlier on Simplicity Esports and Gaming Company (WINR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Simplicity Esports and Gaming Company is an established brand in the esports industry. It has an engaged fan base competing in popular games across diverse genres. These include PUBG, Gears of War, Smite, Guns of Boom, and numerous EA Sports titles. The Company previously went by the name Smaaash Entertainment, Inc. It changed its name to Simplicity Esports and Gaming Company in January of this year. OTCQB-listed, the Company has its head office in New York, New York.

Additionally, Simplicity Esports operates esports gaming centers. These centers provide the public the opportunity to experience and enjoy gaming and esports in a social setting, regardless of skill or experience. Furthermore, the Simplicity Esports stream team includes a unique group of casters, influencers, and personalities. All of them connect to Simplicity Esports and Gaming's dedicated fan base.

The Company's Gaming Centers will feature leading edge technology. This includes high performance PCs, as well as multiple gaming consoles to create a dynamic customer experience.

Simplicity Esports has identified locations for its first five corporate owned retail Esports Gaming Centers. The five locations are throughout Florida, with the first in Boca Raton. The 5 locations will represent roughly 9,000 square feet of gaming space and more than 150 gaming stations. In addition, the Company has started the launch of its Franchise Partner Program. Franchising will further expand Simplicity Esports and Gaming's geographic presence, while promoting the Simplicity brand.

Last week, Simplicity Esports and Gaming announced that its second Esports Center will be located in DeLand, Florida. Simplicity Esports expects its DeLand Esports Center will open in the fiscal quarter ending August 31, 2019. Simplicity Esports targets opening 15 Esports Centers by year end and a total of 50 across the nation in the next 23 months.

Mr. Roman Franklin, President of Simplicity Esports and Gaming, said, "As an alumnus of Stetson University's School of Business Administration, I am excited to bring our Esports Center experience to the DeLand community. The DeLand location will continue the anticipated expansion of our footprint into areas near colleges and universities, as we previously announced at the NAB Conference."

Simplicity Esports and Gaming Company (WINR), closed Wednesday's trading session at $1.59, down 3.05%, on 4,024 volume with 13 trades. The average volume for the last 3 months is 9,995 and the stock's 52-week low/high is $0.56/$11.05.

chart

AmeriCann, Inc. (ACAN)

NetworkNewsWire, Profit Confidential, TipRanks, Insider Financial, Equities, Stockhouse, Market Screener, Financial Buzz, Daily Marijuana Observer, OTC Markets, Trading View, InvestorsHub, Wallet Investor, and MarketWatch reported earlier on AmeriCann, Inc. (ACAN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, AmeriCann, Inc. designs, develops, and owns medical cannabis facilities to produce medical cannabis in the U.S. The Company partners with local businesses to serve marijuana patients in their communities. It is developing state-of-the-art cultivation, processing and product manufacturing facilities. It uses greenhouse technology for cannabis cultivation and is designing GMP Certified cannabis extraction and product manufacturing infrastructure. AmeriCann has its corporate headquarters in Denver, Colorado.

AmeriCann, by way of a wholly-owned subsidiary, AmeriCann Brands, Inc., intends to secure licenses to cultivate cannabis and produce cannabis infused products. This includes beverages, edibles, topicals, vape cartridges, as well as concentrates. AmeriCann Brands, Inc. plans to operate a Marijuana Product Manufacturing business at the Massachusetts Cannabis Center with more than 40,000 square feet of state-of-the art extraction and product manufacturing infrastructure.

Fundamentally, AmeriCann's aim is to serve cannabis patients and consumers through providing state of the art facilities designed and built to produce high quality, consistent cannabis cultivated and processed in a controlled, secure, and sustainable environment. Moreover, regarding its Real Estate Services, AmeriCann employs a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. Furthermore, regarding Licensing Procurement, the Company has been contributory in winning cannabis licenses in competitive application processes across the nation.

Last month, in an effort to explore how medical cannabis can help veterans, AmeriCann announced that it has partnered with the Veterans Health and Cannabis Citizen Science Study in Massachusetts. The research is led by Cannabis Community Care and Research Network (C3RN) and UMass Dartmouth CharltonCollege of Business in collaboration with Veterans Alternative Healing (VAH).

Mr. Tim Keogh, Chief Executive Officer of AmeriCann, said, "We are proud to be a partner of this important research with C3RN and Veterans Alternative Healing. These organizations are doing incredible work to remove the stigma around medical cannabis and increase education and access for all, especially our veterans. We look forward to seeing what this study finds and how it can be helpful to veterans."

Yesterday, AmeriCann announced that construction is progressing quickly and on schedule at its flagship project, the Massachusetts Cannabis Center (MCC). The MCC is undergoing development on a 52-acre parcel situated in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure for the existing medical cannabis and the newly emerging adult-use cannabis marketplace. Building 1 of the MCC, a 30,000 square foot cultivation and processing facility, is scheduled to be completed in August of this year.

AmeriCann has a 15-year Joint Venture Partnership with Bask, Inc. Bask is an existing Massachusetts licensed vertically integrated cannabis operator. AmeriCann will receive a Revenue Participation Fee of 15 percent of Gross Revenue on all products produced and sold from Building 1.

AmeriCann, Inc. (ACAN), closed Wednesday's trading session at $1.261, down 1.87%, on 56,900 volume with 102 trades. The average volume for the last 3 months is 41,677 and the stock's 52-week low/high is $0.81/$4.69.

chart

Bay Banks of Virginia, Inc. (BAYK)

Zacks, MarketWatch, Dividata, Insider Tracking, Wallmine, Infront Analytics, Business Insider, Dividend Investor, Invest Tribune, Market Screener, Stockhouse, GuruFocus, Wallet Investor, 4-Traders, Morningstar, Stockopedia, Simply Wall St, OTC Markets, PR Newswire, and InvestorsHub reported previously on Bay Banks of Virginia, Inc. (BAYK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Founded in 1930, Bay Banks of Virginia, Inc. is the holding company of Virginia Commonwealth Bank and VCB Financial Group, Inc. By way of its subsidiaries, it provides diverse banking products and services to businesses, professionals, and consumers in the State of Virginia. As of February 6, 2019, it operated 20 banking offices, including a production office located throughout the greater Richmond area, the Northern Neck region, Middlesex County, the Tri-Cities area of Petersburg, Hopewell and Colonial Heights, Suffolk, and Virginia Beach. OTCQB-listed, Bay Banks of Virginia is based in Richmond, Virginia.

Virginia Commonwealth Bank serves businesses, professionals, and consumers with a broad array of financial services, including retail and commercial banking, and mortgage banking. VCB Financial Group provides management services for personal and corporate trusts. This includes estate planning, estate settlement and trust administration, and investment and wealth management services.

The Company accepts checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, and individual retirement accounts. Its loan products include commercial and industrial loans; residential and commercial mortgages; home equity loans; consumer installment loans; and consumer loans.

Additionally, it offers credit cards; investment accounts; and insurance, online banking, telephone banking, mobile banking, analysis checking, cash management deposit, wire, direct deposit payroll, and remote deposit services, and also a line of commercial lending options. It also offers management services, and trust administration, investment, and wealth management services; and revocable and irrevocable living trusts, testamentary trusts, custodial accounts, investment management accounts, and managed and self-directed rollover individual retirement accounts for personal and corporate trusts.

Yesterday, Bay Banks of Virginia announced financial results for Q1 ended March 31, 2019. It reported Net Income of $1.5 million, or $0.11 per diluted share, for Q1 of 2019 versus $782,000, or $0.06 per diluted share, for Q4 of 2018 and $1.1 million, or $0.09 per diluted share, for Q1 of 2018.

Net Income in Q1 of 2018 included $363,000 ($287,000 after income tax) of merger-related expenses in connection with its merger with Virginia BanCorp, Inc. on April 1, 2017. Mr. Randal R. Greene, President and Chief Executive Officer, said: "I am pleased to report improved first quarter 2019 results, which reflect the strongest quarterly earnings reported since the Merger. Our results reflect an intentional slowing of loan growth as we exercise a disciplined approach of investing our liquidity in higher yielding loans…"

Bay Banks of Virginia, Inc. (BAYK), closed Wednesday's trading session at $8.00, up 1.65%, on 19,000 volume with 38 trades. The average volume for the last 3 months is 18,968 and the stock's 52-week low/high is $7.01/$10.19.

chart

MRI Interventions, Inc. (MRIC)

Street Insider, TipRanks, Wallet Investor, Stockhouse, InvestorsHub, EarningsCast, YCharts, Equity Clock, 4-Traders, Last10k, Market Screener, Simply Wall St, Trading View, and Proactive Investors reported earlier on MRI Interventions, Inc. (MRIC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MRI Interventions, Inc. creates unique platforms for performing the next generation of minimally invasive surgical procedures in the brain. A medical device company, it develops and commercializes inventive platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI guidance. The Company is developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration and gene therapy. OTCQB-listed, MRI Interventions is based in Irvine, California.

The Company has two product platforms: the ClearPoint® system and the ClearTrace system. Its ClearPoint® system is in commercial use. It is used to perform minimally invasive surgical procedures in the brain. The ClearTrace system is still in development. It will be used to perform minimally invasive surgical procedures in the heart. Both systems use intra-procedural magnetic resonance imaging to guide the procedures. The design of both systems is to work in a hospital's existing MRI suite.

MRI Intervention's belief is that its ClearPoint system may enable physicians to treat patients who otherwise may not be treated utilizing present surgical techniques. Furthermore, by providing direct, intra-procedural visualization, the Company believes its ClearPoint system could lessen the amount of time needed to perform procedures and enable physicians to treat more patients in a given period of time.

Recently, MRI Interventions congratulated Dr. Clark Chen on the first patient treated in a Phase II clinical trial, which uses a modified virus for the treatment of glioblastoma (GBM) to utilize MRI Intervention's ClearPoint® Neuro Navigation System.

Mr. Zach Carr, Portfolio Manager for Biologics and Drug Delivery at MRI Interventions, said, "We commend Dr. Chen on this significant milestone in his clinical program. The ability for MRI Interventions to work closely with cutting edge therapies and premier academic centers continues to position us and our expertise in the biologic space. Driving the utilization of real-time MRI-guided neuro-navigation while also supporting our partners in their clinical trials serves as an important foundation of our overall growth strategy. We are excited to continue our work with Dr. Chen on this and other ground-breaking efforts."

For Q1 2019, MRI Interventions increased first quarter Revenue 52 percent year-over-year to $2.5 million. The Company reported $1.6 million in quarterly functional neurosurgery revenue. This represents an increase of 38 percent over the year ago first quarter.

MRI Interventions reported biologics and drug delivery Revenue of $382,000, an increase of 93 percent over the previous year, including first European shipments to Lysogene for use in their P4-SAF-302 trial. The Company reported Capital Sales and Other Services Revenue of $486,000, which includes two system sales. The systems sales, combined with three evaluation installations, brings the total U.S. installed base to 63 systems.

MRI Interventions, Inc. (MRIC), closed Wednesday's trading session at $3.05, up 7.39%, on 32,799 volume with 62 trades. The average volume for the last 3 months is 6,013 and the stock's 52-week low/high is $1.33/$3.74.

chart

Stereotaxis, Inc. (STXS)

NetworkNewsWire, StockTwits, Zacks, EarningsCast, Market Screener, Simply Wall St, Equity Clock, GuruFocus, MarketWatch, Insider Financial, Equities, 4-Traders, Proactive Investors, YCharts, Wallet Investor, InvestorsHub, Stockhouse, Barchart, and Insider Tracking reported earlier on Stereotaxis, Inc. (STXS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Stereotaxis, Inc. is the worldwide leader in innovative robotic technologies for the treatment of cardiac arrhythmias. The design of these robotic technologies are to enhance the treatment of arrhythmias and perform endovascular procedures. More than 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis' systems have received regulatory clearance in the U.S., Canada, the European Union (EU), Japan, China, and elsewhere. Stereotaxis is headquartered in St. Louis, Missouri.

The Company's mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide premier patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables.

Stereotaxis provides increased efficacy and efficiency in combination with a first-in-class safety profile in ventricular arrhythmias, congenital procedures, and certain other special situations. The validation of the value provided in these procedures is in the fact that many top hospitals have adopted Stereotaxis for all of their ventricular procedures and have seen considerable growth following adoption of the technology.

Recently, Stereotaxis and Acutus Medical announced the first patients were successfully treated using integrated Stereotaxis Robotic Magnetic Navigation and Acutus AcQMap systems. The integrated technologies are cleared for use in Europe with more regulatory clearances expected in the coming months.

The therapeutic approach used in these first patients combines high-resolution real-time cardiac imaging and mapping from Acutus' AcQMap system with the extraordinary precision and stability of the Stereotaxis Robotic Magnetic Navigation system. The integration of these advanced technologies enables physicians to clearly see a patient's arrhythmia pattern and subsequently reach those targets to deliver therapy with the accuracy of robotic navigation. The first integrated procedures were conducted by Dr. Tamas Szili-Torok of Erasmus Medical Center in Rotterdam, The Netherlands.

Stereotaxis will participate in and showcase its innovation initiatives at the 40th Annual Heart Rhythm Scientific Sessions that will take place May 8-11, 2019, in San Francisco, California. The feature presentation by Mr. David Fischel, Chairman and Chief Executive Officer, will highlight Stereotaxis' innovation accomplishments and strategy. It will take place on Wednesday, May 8 at 5:30 p.m. Pacific Time at the Stereotaxis booth.

Stereotaxis, Inc. (STXS), closed Wednesday's trading session at $2.00, up 5.26%, on 40,984 volume with 32 trades. The average volume for the last 3 months is 64,549 and the stock's 52-week low/high is $0.513/$2.45.

chart

Namaste Technologies, Inc. (NXTTF)

MicroSmallCap, Micro Cap Daily, Marijuana Stocks, Make Penny Stocks Great Again, Midas Letter, Green Leaf Pot Stocks, Stockhouse, InvestorsHub, Trading View, Profit Confidential, Proactive Investors, Insider Financial, Wallet Investor, Barchart, Daily Marijuana Observer, and Stockwatch reported previously on Namaste Technologies, Inc. (NXTTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Namaste Technologies, Inc. powers the ultimate online customer experience for medicinal cannabis and related products. The Company, via its subsidiaries, operates as a cannabis e-commerce business. In addition, Namaste provides vaporizers and accessories across a number of platforms operating in greater than 20 countries on 3 continents. Namaste Technologies has its corporate headquarters in Vancouver, British Columbia.

The Company has its NamasteMD.com. This is its integrated telemedicine application. Namaste connects medical clients with health care practitioners to more readily issue and renew cannabis prescriptions online. Namaste Technologies also has its Cannmart.com. This is an 'everything cannabis store' offering clients a large assortment of strains to fill their prescription needs. Cannmart.com features the first Canadian Medical Sales-Only Licence. Moreover, Namaste Technologies' innovative artificial intelligence (AI) engine incorporated in its platforms and related Uppy App, completes the Company's ecosystem by identifying the right product and pairing to address specific medical cannabis needs.

Namaste Technologies has 24 unique websites and five warehouses. Numerous international warehouses allow products to be shipped fast, safely, as well as securely to almost 2 million customers. In March, Namaste Technologies announced that it entered into a share purchase agreement to acquire 49 percent of the issued and outstanding shares of Calgary, Alberta based Choklat, Inc. for $1.5 million in cash consideration. As part of the acquisition, the Company will appoint a member to the Board of Choklat. Choklat is a premium chocolate manufacturer. It has existing sales via its online eCommerce site and through a network of distributors throughout Canada.

Moreover, in March, Namaste Technologies announced it completed the earlier announced acquisition of 49 percent of the common shares of Toronto-based Pineapple Express Delivery, Inc. In June 2018, Namaste announced that it entered into a subscription agreement to acquire 15 percent of the common shares of Pineapple for $1,000,000 that consisted of $850,000 in cash and $150,000 in Namaste common shares. In December 2018, it announced that it entered into a binding agreement with shareholders of Pineapple Express to acquire an additional 34 percent of the outstanding common shares of Pineapple Express. Following closing of the Transaction, Namaste Technologies now owns 49 percent of the issued and outstanding common shares of Pineapple Express.

Namaste Technologies continues to invest in technology and infrastructure spending to position it to cater to domestic and global licensed producers, cultivators, micro-growers and ancillary device producers who may wish to distribute products via Namaste's proposed marketplace that is now under development. Namaste believes that as its end-to-end business proposition develops, it will be in a position to migrate the benefits of the user interface, user experience flows and integration between CannMart and its other properties to the new marketplace business model.

Namaste is continuing to concentrate on improving the customer experience for customers who visit its properties to buy cannabis products and acquire medical prescriptions for Cannabis. Namaste has made advancements to Namaste MD, improved its focus on operational execution at CannMart, and made further advancements at CannMart Labz.

Namaste Technologies, Inc. (NXTTF), closed Wednesday's trading session at $0.56, up 6.75%, on 1,740,970 volume with 643 trades. The average volume for the last 3 months is 1,121,050 and the stock's 52-week low/high is $0.362/$3.049.

chart

Altigen Communications, Inc. (ATGN)

NetworkNewsWire, Zacks, Stock Twits, Equity Clock, Wallet Investor, Simply Wall St, Stockhouse, OTC Markets, YCharts, Last10k, Street Insider, Capital Cube, Marketwired, 4-Traders, Dividend Investor, Market Screener, Investors Hangout, and InvestorsHub reported earlier on Altigen Communications, Inc. (ATGN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Altigen Communications, Inc. is a provider of Hosted Skype for Business and Contact Center solutions. The Company's expertise is in Microsoft communications technologies, with over two decades of experience developing, deploying and supporting Unified Communications solutions built on Microsoft platforms. A foremost Microsoft Cloud Solutions provider, Altigen delivers fully managed Unified Communications services, combining Hosted Skype for Business, Advanced Cloud PBX, and Innovative Cloud Contact Center applications with seamless integration to Office 365 for small-to-medium sized businesses and enterprises. OTCQB-listed, Altigen Communications is headquartered in San Jose, California.

The Company's innovative and feature rich Cloud PBX and Multi-channel Contact Center solutions natively integrate with Skype for Business and Office 365 to deliver business-critical functionalities needed by SMBs and enterprises. The design of Altigen solutions are for high reliability, user-friendliness, seamless integration to Microsoft infrastructure technologies. In addition, they are built on a scalable, open standards platform.

Altigen's portfolio of Cloud-based Unified Communications solutions considerably simplifies deployment and ongoing system management. This is while enabling its customers to significantly decrease IT (Information Technology) support costs and lessen total cost of ownership.

Recently, Altigen Communications announced a strategic business partnership with Cisilion. The focus of the partnership between the two companies will be on delivering and enhancing the value of Microsoft Teams Phone System and Skype for Business. Cisilion is a foremost UK headquartered IT systems integrator and managed service provider. It specializes in enterprise networking, voice and collaboration, security, cloud & data center and IT services.

Mr. Paul Fullman, Altigen Communications' Vice President of Microsoft Solutions, said, "The momentum for Microsoft Teams has been steadily growing for the past year. With many organizations now in the process of evaluating Microsoft Teams Phone System, it was critical for us to work with a top-notch partner to deliver Altigen's solutions. We're extremely pleased with such a quality company as Cisilion."

Last week, Altigen Communications announced its financial results for Q2 ended March 31, 2019. Revenue for Q2 of fiscal 2019 was $2.5 million, versus $2.8 million in the prior quarter, and compared to $2.5 million in the previous year quarter. Gross Margin in Q2 of fiscal 2018 was 81.7 percent, versus 82.9 percent in the prior quarter, and compared to 84.3 percent during Q2 of fiscal 2018. The decrease in the Company's Gross Margin was mainly due to a shift in its product mix.

GAAP Net Income for Q2 of fiscal 2019 was $403,000, or $0.02 per diluted share. This is in comparison to Net Income of $612,000, or $0.02 per diluted share in the prior quarter, and compared to Net Income of $383,000, or $0.02 per diluted share during the same period the year prior.

Altigen Communications, Inc. (ATGN), closed Wednesday's trading session at $1.24, up 3.33%, on 38,521 volume with 41 trades. The average volume for the last 3 months is 74,840 and the stock's 52-week low/high is $0.379/$1.47.

chart

Aurania Resources Ltd. (AUIAF)

Gold Telegraph, Wallmine, Stockhouse, MarketWatch, Junior Mining Network, Wallet Investor, Market Screener, Gold Stock Data, Metals News, Morningstar, The Street, Dividend Investor, Northern Miner, Seeking Alpha, GuruFocus, Investors Hangout, Barchart, Trading View, and Stockwatch reported previously on Aurania Resources Ltd. (AUIAF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Aurania Resources Ltd. engages in the identification, evaluation, acquisition and exploration of mineral property interests. The Company's emphasis is on precious metals and copper. Aurania's flagship asset is The Lost Cities - Cutucu Project. This Project is in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador. A junior mineral exploration company and OTCQB-listed, Aurania Resources is headquartered in Toronto, Ontario.

The Lost City Project is in the SE part of the Republic of Ecuador, in the Province of Morona-Santiago. The Project comprises circa 208,000 hectares in 42 concessions occupying the central part of the Cordillera de Cutucu. These concessions extend roughly 95 km along the Cordillera. The Cordillera de Cutucu is contiguous with the Cordillera del Condor to the south, together forming foothills on the Amazon-side of the Andes mountain chain. Aurania Resources' exploration is centered on finding the same kinds of deposits that occur in the Cordillera del Condor.

To date, eleven targets for gold-silver mineralization, four copper targets and one silver-zinc-lead target have been identified at The Lost Cities - Cutucu Project. Historical information led to the staking of 500,000-plus acres (208,000 Hectares or 2,080km2). The concession area is along-trend of a very well-endowed mineral belt.

Aurania Resources' operational strategy includes completing initial exploration work on its large land package (stream sediment sampling and geophysics). The Company's strategy also includes completing scout drilling of epithermal gold targets and continuing exploration for copper - initiating scout drilling on key copper targets.

This month, Aurania Resources reported the Tsenken target in the Lost Cities - Cutucu Project has been enlarged by 6 kilometers (km). High-grade copper and silver have now been found over a 9km long trend. Recent grab samples from boulders in streams contain up to 7 percent copper with 70 grams per tonne (g/t) silver. Follow-up exploration of these streams has led to the discovery of copper and silver in outcrop.

In addition, this month, Aurania Resources reported that high-grade copper and silver have been found over an area measuring 6 km by 3km in the Kirus target area in the Lost Cities - Cutucu Project. Samples from boulders in streams contain up to 12 percent copper with 166 grams per tonne (g/t) silver. Follow-up exploration of these streams has led to the discovery of outcrop with grades of up to 5 percent copper with 70g/t silver.

Aurania Resources Ltd. (AUIAF), closed Wednesday's trading session at $2.9696, up 1.01%, on 2,454 volume with 5 trades. The average volume for the last 3 months is 7,904 and the stock's 52-week low/high is $1.025/$3.05.

chart

Appliqate, Inc. (APQT)

Penny Stock Hub, Valuespectrum, Stockwatch, Market News Desk, InvestorsHub, Wallet Investor, GuruFocus, Dividend Investor, MarketWatch, GlobeNewswire, Stockhouse, Stockopedia, Trading View, Seeking Alpha, OTC Markets, and Interactive Brokers reported earlier on Appliqate, Inc. (APQT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets, Appliqate, Inc. operates as a marketing and technology company. It concentrates on text message marketing and loyalty rewards via text marketing. The Company offers a broad range of products. It engages customers by way of digital marketing. A Wyoming Corporation, Appliqate has its corporate headquarters in Draper, Utah.

The Company serves customers in the United States. In essence, Appliqate is an innovative new tool a business can use to contact their customers and keep their business fresh in their mind via Appliqate's Text Marketing Campaigns.

Appliqate's campaigns include Text Marketing; Bounceback; Vote; Trivia; Feedback; Text to Win; Spend Tracking; and Punch Card. For example, a Bounceback campaign permits a business to set up a keyword and build a database list of clients that have requested information. A Feedback campaign allows a business or organization to collect information from a client or group of clients.

Last month, Appliqate officially declared the successful launch of Onlichain. This is its blockchain accelerator business model. Together with this launch, Appliqate announced the appointment of technology entrepreneur, Mr. Darren Olayan, to spearhead the Onlichain business.

Via the acquisition of certain assets, Appliqate will provide founders with a full-stack, "idea to exit" blockchain business ecosystem. Through applying unique technology, an international talent pool, aligned capital, and a new exponential mindset, Appliqate can offer a platform that lessens risk, increases positive outcomes for start-ups, opens opportunities for entrepreneurs worldwide, and provides transparency and liquidity to entrepreneurs and their investors.

Additionally, last month, Appliqate announced it acquired a minority stake in Utah-based NUI Social (Nui). Furthermore, Appliqate acquired ownership of its digital wallet assets and intellectual property (IP). Established in 2017, NUI has greater than 300,000 trained sales reps. The NUI sales rep program provides people the opportunity to earn money through bringing exposure to digital applications on an assortment of platforms.

Moreover, the equity and asset purchase bring a strategic partnership, permitting NUI members to apply for the 88,572 person speciality blockchain sales force (Appliqate Affiliates), Appliqate is recruiting and training to launch more blockchain companies. This partnership allows Appliqate to promote blockchain products with reps specifically educated in blockchain while at the same time taking advantage of the large NUI network.

The Appliqate platform will help speed up the growth of companies centered on blockchain. The platform will also create awareness of those companies by members of the worldwide blockchain and cryptocurrency community.

Appliqate, Inc. (APQT), closed Wednesday's trading session at $2.95, even for the day, on 997 volume with 4 trades. The average volume for the last 3 months is 648 and the stock's 52-week low/high is $0.03/$3.00.

chart

Relmada Therapeutics, Inc. (RLMD)

NetworkNewsWire, Super Stock Screener, Micro Cap Daily, Marketbeat, 4-Traders, Market Screener, Zacks, StreetWise Reports, Stockhouse, Trading View, Capital Cube, Dividend Investor, Simply Wall St, Street Insider, Wallet Investor, and Real Investment Advice reported beforehand on Relmada Therapeutics, Inc. (RLMD), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage company, Relmada Therapeutics, Inc. is developing novel therapies for the treatment of central nervous system (CNS) diseases. The Company's lead program is dextromethadone (REL-1017). This is an N-methyl-D-aspartate (NMDA) receptor antagonist. Relmada Therapeutics lists on the OTC Markets Group's OTCQB. The Company is headquartered in New York, New York.

NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with an array of cognitive, neurological and behavioral symptoms. Relmada Therapeutics is targeting major advances in the treatment of CNS disorders.

REL-1017 (dextromethadone), the novel NMDA receptor antagonist, is in Phase 2 clinical testing for the treatment of depression, and preclinical development for Rett syndrome and other indications. REL-1017 is the Company's most-advanced new chemical entity. As a single isomer of racemic methadone, d-Methadone has been shown to possess NMDA receptor antagonist properties with almost no opioid activity or ketamine-like toxicities at the expected therapeutic doses.

Relmada Therapeutics' product candidates also include REL-1015 (LevoCap ER). REL-1015 is a novel version of a proven drug product. REL-1015 is an extended release, abuse deterrent, proprietary formulation of the opioid analgesic levorphanol that is pharmacologically differentiated from morphine, oxycodone, and other strong opioids for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment.

Another product candidate is REL-1028 (BuTab). A novel version of a proven drug product, REL-1028 represents novel oral formulations of modified release buprenorphine undergoing development for chronic pain and opioid dependence indications.

Relmada also has its MepiGel (REL-1021) product candidate. A novel version of a proven drug product, MepiGel (REL-1021) is a proprietary topical dosage form of the local anesthetic mepivacaine for the treatment of painful peripheral neuropathies, including painful diabetic neuropathy, postherpetic neuralgia, and painful HIV-associated neuropathy.

Last week, Relmada Therapeutics announced that results of its N-methyl-D-aspartate receptor (NMDAR) antagonist REL-1017 (dextromethadone) single ascending dose and multiple ascending dose studies were accepted for publication in the peer reviewed Journal of Clinical Psychopharmacology. REL-1017 is presently in a Phase 2 study in individuals with major depressive disorder (MDD) who have not responded to traditional antidepressants. The design of the Phase 2, multicenter, randomized, double-blind, placebo-controlled, three arm study is to assess the safety, tolerability, and antidepressant effect of REL-1017 at two doses (25 mg QD and 50 mg QD) as an adjunctive therapy in the treatment of patients diagnosed with major depressive disorders.

Relmada Therapeutics, Inc. (RLMD), closed Wednesday's trading session at $1.82, up 0.55%, on 47,315 volume with 70 trades. The average volume for the last 3 months is 23,359 and the stock's 52-week low/high is $0.80/$2.01.

chart

Delta 9 Cannabis, Inc. (VRNDF)

Stock Street News, Can Stock Watch, Stockhouse, CannabisMarketCap, Dividend Investor, MarketWatch, Tip Ranks, Pot Stock News, PR Newswire, Investorx, Stockwatch, 4-Traders, Wallmine, The Street, Wallet Investor, TheNewswire, Market Screener, Trading View, New Cannabis Ventures, GuruFocus, InvestorsHub, Midas Letter, and Barchart reported earlier on Delta 9 Cannabis, Inc. (VRNDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Delta 9 Cannabis, Inc. is a vertically integrated cannabis company based in Winnipeg, Manitoba. Its focus is to bring the highest quality cannabis products to market. The Company's wholly-owned subsidiary, Delta 9 Bio-Tech, Inc., is a licensed producer of medical and recreational cannabis. Delta 9 Bio-Tech operates an 80,000 square foot production facility in Winnipeg. Delta 9 now operates three retail stores, two in Winnipeg, Manitoba and one in Brandon, Manitoba. A fourth retail store in Thompson, Manitoba is scheduled to open in June 2019. The Company owns and operates these stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis lists on the OTC Markets' OTCQX.

The Company's plan is to increase its annual cannabis production capacity to 60,000 kilograms per year by 2022. Delta 9 Cannabis' Winnipeg production facility uses proprietary grow pod technology to produce premium cannabis products. Delta 9 was the first company in Canada to develop and deploy stackable, self-contained grow pod technology.

With these self-contained units there is low risk of crop failure. Each grow pod is constructed from a repurposed 320 square foot steel shipping container. Each can produce roughly 32.5 kilograms of cannabis per year. Company Management estimates that each grow pod can generate $320,000 in annual revenue from the sale of cannabis produced by each grow pod.

Delta 9 Cannabis, via its partially-owned subsidiary, Delta 9 Lifestyle Cannabis Clinic, Inc., opened its first retail cannabis store in Winnipeg, Manitoba on October 17, 2018. The Company has partnered with a Manitoba First Nation to open a fifth store. Also, Delta 9 has prequalified for the Manitoba government's request for proposals to build additional stores in smaller, rural communities.

Yesterday, Delta 9 Cannabis announced financial and operating results for the year ending December 31, 2018. Selected 2018 year end financial highlights include record Operating Revenues of $7.57M for the year ending December 31, 2018. This is up 702 percent, from $944,114 for the year ending December 31, 2017. The Company had record Gross Profit of $5.74M for the year ending December 31, 2018. This is up 1,200 percent, from $442,681 for the year ending December 31, 2017. Net Income was a Loss of $8.61M for the year ending December 31, 2018, mainly because of expanding operations in advance of legalization of recreational use cannabis in Q4 of 2018.

Expansion in 2018 increased the number of Delta 9 grow pods approved by Health Canada to 154 from 15, increasing expected annual production capacity to greater than 4,200 Kg of dried cannabis flower. The Company announced its intention to become a preferred supplier of medical cannabis to Pharmasave, a national pharmacy chain with about 650 retail outlets. Additionally, Delta 9 entered into a supply agreement for 2.3M grams of cannabis with the Province of Manitoba. Moreover, the Company entered into an agreement to supply 1,000 Kg of cannabis per year for 10 years to Auxly Cannabis Group, Inc.

Delta 9 Cannabis, Inc. (VRNDF), closed Wednesday's trading session at $1.15, even for the day, on 7,255 volume with 11 trades. The average volume for the last 3 months is 25,155 and the stock's 52-week low/high is $0.654/$1.85.

chart

NeuroOne Medical Technologies Corporation (NMTC)

Micro Small Cap, Wallmine, Insider Tracking, Stockwatch, Simply Wall St, The Financials, GuruFocus, Market Screener, Trading View, Dividend Investor, Infront Analytics, InvestorsHub, Marketbeat, Stockhouse, and Real Investment Advice reported on NeuroOne Medical Technologies Corporation (NMTC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

NeuroOne Medical Technologies Corporation centers on revolutionizing the standard of care for patients suffering from conditions including epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain disorders. The Company's belief is that its thin film electrodes will be able to be placed with minimally invasive procedures and improve the outcomes for patients with neurological disorders. NeuroOne Medical Technologies has its corporate office in Eden Prairie, Minnesota. The Company lists on the OTC Markets' OTCQB.

Furthermore, NeuroOne's belief is that the higher resolution provided by its electrodes can enable the usage of powerful computing techniques, including machine learning and artificial intelligence (AI). Last year, the Company recruited thought leaders and highly renowned AI neurosurgeons to create its Artificial Intelligence Advisory board. In addition, it established its headquarters, conducted numerous rounds of pre-clinical testing on its ablation electrode at Cleveland Clinic, and a pre-clinical feasibility study for minimally invasive placement of its cortical electrodes at Mayo Clinic.

For this year, NeuroOne Medical Technologies expects to debut its cortical electrodes, pending Food and Drug Administration (FDA) 510(k) clearance. The Company submitted a 510(k) filing to the FDA for its cortical electrode product line. It plans to submit its depth electrode product line later in 2019. Upon clearance, NeuroOne's intention is to launch its electrode products to targeted industry leading, medical centers. In addition, it plans on exploring more product applications with insight from its AI Advisory Board.

Last week, NeuroOne Medical Technologies announced the hiring of Mr. Steve Mertens as Chief Technology Officer. Before joining NeuroOne, Mr. Mertens was Sr. Vice President of R&D and Operations at Nuvaira, a privately held lung denervation company developing minimally invasive products for obstructive lung diseases. Prior to that, he was a Senior Vice President of Research and Development for Boston Scientific.

NeuroOne Medical Technologies' President and Chief Executive Officer, Mr. Dave Rosa, said, "As we transition from a development-stage company to a commercial entity, I'm looking forward to having Steve as part of our team. His expertise in medical device development, operations, and quality assurance will be invaluable for us as we further advance our product initiatives."

NeuroOne Medical Technologies Corporation (NMTC), closed Wednesday's trading session at $3.95, even for the day, on 8,897 volume with 8 trades. The average volume for the last 3 months is 16,901 and the stock's 52-week low/high is $3.00/$10.00.

chart

The QualityStocks Company Corner

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Cannabis firm Green Growth Brands (CSE:GGB) (OTCQB:GGBXF) has been on a high streak lately as its stock climbed as much as 30% on the Canadian Securities Exchange since April 16. The sudden spike in the stock is due to the fact that Green Growth Brands has managed to launch a proprietary cannabis product, followed by other brand lines derived from the same proprietary product.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.6867, up 4.14%, on 395,692 volume with 610 trades. The average volume for the last 3 months is 232,331 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, the Founder of the Company, notified the Company's Board of Directors on April 25, 2019 that he plans to step down as President and CEO effective September 9, 2019.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.15, up 6.78%, on 7,400 volume with 39 trades. The average volume for the last 3 months is 16,409 and the stock's 52-week low/high is $1.52/$4.10.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) today announces its expansion into the cannabidiol (CBD) retail space through 'FLORAH,' the newest addition to the Company's operational and investment portfolio. FLORAH is a concept boutique that educates consumers of the benefits of CBD while a curating a best of selection of CBD lifestyle, wellness, beauty and pet products. The company's flagship location is on Melrose Ave in West Hollywood. Also today, the company was highlighted in an article looking at how New York-based investment bank Cowen & Co. released a study on the CBD (cannabidiol) market. Of the findings, one of the most intriguing was that nearly 7 percent of the 2,500 polled, said they had used CBD, an active ingredient in marijuana that purportedly provides relief to patients without getting them high, as a supplement.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.17, up 1.74%, on 32,003 volume with 94 trades. The average volume for the last 3 months is 93,526 and the stock's 52-week low/high is $0.75/$5.94.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the innovative ice cream company solving America's $50 billion-dollar nighttime snacking problem, announced today that the company has scheduled a fourth ice cream production run for June of 2019. The Company already has production scheduled for mid-May, but an additional run has been necessitated by a major distribution partnership agreement the Company signed earlier this week.  The June production run will be the fourth production run in the first half of the year for the ice cream startup, and the largest to date. 

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.64, up 2.24%, on 380,243 volume with 104 trades. The average volume for the last 3 months is 563,483 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

An agreement between wellness brand builder Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and wholesale medicinal product distributor Two Towers indicates that doors are opening to a potential array of important new markets for Wildflower as the company builds on its partner's established capabilities.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.5386, up 2.01%, on 27,289 volume with 9 trades. The average volume for the last 3 months is 23,644 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) has named Jon Paul as its new CFO, reporting to co-founder and company CEO Jake Heimark. Previously, Paul was CEO and founder of Value-Added Finance Resources, an advisory firm. He replaces Craig Heimark, who has been named PLUS' chief strategy officer. Heimark remains as chairman, secretary and director of the company (http://nnw.fm/48HHy).

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.4201, up 0.30%, on 90,609 volume with 229 trades. The average volume for the last 3 months is 87,481 and the stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group Inc. (OTCQB: TRXD), an integrated pharmaceutical services company, is extending the reach of DelivMeds, the company's innovative mobile app that allows patients to receive same-day dispensed prescriptions and medication refills from a local, independent pharmacist with no delivery fees incurred. In an interview with Proactive Investors, Trxade Group CEO Suren Ajjarapu discussed the expansion of DelivMeds throughout the company's growing network of independent pharmacies around the U.S. (http://nnw.fm/4NrBT).

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed the day's trading session at $0.44, even for the day, on 2 volume. The average volume for the last 3 months is 2,595 and the stock's 52-week low/high is $0.23/$1.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), in conjunction with its 49.18 percent owned Epican Medicinals, this morning announced the opening of its second legal cannabis retail store in Jamaica. To view the full press release, visit: http://nnw.fm/KG8sy. Also today, the company was highlighted in an article examining how this year, consumers will be seeing more beauty products infused with cannabidiol (CBD) hemp oil.  Following the passage of the 2018 Farm Bill, more companies are now free to develop products with the cannabidiol (CBD) as an ingredient.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.29, off by 1.79%, on 669,028 volume with 1,076 trades. The average volume for the last 3 months is 1,304,777 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Consumer healthcare company Geyser Brands (TSX.V: GYSR) engages in the development and marketing of cannabis products and brands in the nutraceutical, cosmetics, food-and-beverage and pet sectors. To view the full article, visit: http://nnw.fm/YyHa8.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.84, off by 1.18%, on 16,340 volume with 9 trades. The average volume for the last 3 months is 8,378 and the stock's 52-week low/high is $0.254/$0.446.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN) was featured today in the 420 with CNW by CannabisNewsWire. While many of the reported benefits of cannabis are backed by scientific evidence, others haven't yet been subjected to scientific scrutiny. However, cannabis' role in helping to combat addiction problems has received overwhelming support from addition specialists in Canada.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.71, off by 1.25%, on 5,812 volume with 7 trades. The average volume for the last 3 months is 27,885 and the stock's 52-week low/high is $0.07/$0.722.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) was highlighted today in an article from CannabisNewsWire. Projections for the cannabis markets are staggering, yet there's evidence that the lofty estimates may be understated. Once viewed as wild conjecture for the future of cannabis markets, forecasts in 2015 fell severely short of actuality.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.625, off by 4.29%, on 2,720,399 volume with 953 trades. The average volume for the last 3 months is 670,565 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Innovative Properties Inc. d/b/a Nabis Holdings (CSE: NAB; OTC: INNPF; FRA: 71P) ("Nabis" or the "Company"), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, is pleased to announce that it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC Market in the United States.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."

Strategy

While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.456, off by 2.77%, on 76,173 volume with 62 trades. The average volume for the last 3 months is 501,497 and the stock's 52-week low/high is $0.417/$0.791.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Oil and gas industry technology developer Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) announced significant milestones as it closed out the year's first quarter, reporting continuous production at a rate of over 500 barrels per day (bpd) and the sale of two loads of barrels of heavier-than-usual crude at an API gravity of 17 from its eastern Utah facility.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.266, off by 1.02%, on 39,193 volume with 21 trades. The average volume for the last 3 months is 148,657 and the stock's 52-week low/high is $0.242/$1.43.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Canadian iron ore exploration and development company Black Iron's (TSX: BKI) (OTC: BKIRF) (GR: BIN) primary focus is on the advancement of its Shymanivske iron ore project located  in the historically rich Kryvyi Rih region of Ukraine. To view the full article, visit: http://nnw.fm/iw0nX.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.0486, off by 17.06%, on 50,000 volume with 6 trades. The average volume for the last 3 months is 56,255 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.